Bill Reddick is a seasoned executive with decades of experience in starting,
funding and operating companies across the finance and healthcare
industries. Most recently, Bill was the founder and CFO of Celtaxsys, a
privately held drug discovery and development company, where he guided
the lead asset, a drug for cystic fibrosis, through Phase 3. Celtaxsys raised
over $80 million in capital, including a $40 million Series D. Prior to
Celtaxsys Bill founded Masters Capital Management, a hedge fund that
invests in public and private domestic and international bonds and equities.
Under Bill’s management assets increased from $700,000 to $650,000,000
between 1994 and 2005. Bill is passionate about the science and business of
disease and healing and is committed to turning scientific innovation into
therapies for patients.